Press releases

12/12/2014 09:30
|

Catherine Llorens-Cortes receives the 2014 Galien France pharmaceutical research award for her work on the key role of angiotensin III at brain level in the control of blood pressure

08/12/2014 18:00
|

Quantum Genomics receives a 3 M EUR financing

27/11/2014 18:20
|

Quantum Genomics announces the appointment of Dr Olivier Madonna as Chief Medical Officer

17/11/2014 18:00
|

Quantum Genomics receives all regulatory approvals to start its Phase II clinical trial in hypertension

05/11/2014 08:00
|

Publication of an independent equity research by Aurgalys

27/10/2014 18:00
|

Quantum Genomics announces the appointment of international experts as members of its Scientific Advisory Board

02/09/2014 18:00
|

Quantum Genomics receives financial aid from Bpifrance (France Public Innovation Bank) for its research program evaluating combinations of its new class of molecules with other anti-hypertensive compounds

08/07/2014 18:00
|

Professor Pierre Corvol appointed Chairman of the Scientific Advisory Board of Quantum Genomics

18/06/2014 18:00
|

Quantum Genomics disclosed the final results of phase I clinical trials for QGC001 during the joint Meeting of the European and International Societies of Hypertension (ESH-ISH) in Athens (Greece)

15/05/2014 09:20
|

Quantum Genomics strengthens its management team by appointing Marc Karako, Chief Financial Officer, and Jean-Philippe Milon, Chief Operating Officer

25/04/2014 17:45
|

Additional private placement of EUR 240K : total fundraising increased to EUR 3.650 K in 2014

09/04/2014 08:45
|

Quantum Genomics transfers its shares to Alternext Paris as of April 10, 2014, following a capital increase of EUR 3.4 million

10/01/2014 10:00
|

ANR provides a grant of EUR 1 million for the implementation of a research program with the QGC001